Cancer

Research leads to new drug for hard-to-treat lymphomas

Japan has become the first country to approve a lymphoma drug developed through research at Albert Einstein College of Medicine. This also marks the first time that an Einstein-licensed drug has been approved for patient ...

Apr 17, 2017
popularity5 comments 0

New insight illuminates how cells respond to stress

Duke Cancer Institute scientists have described a previously unknown series of steps that cells undergo when stressed, adding crucial information to the understanding of DNA damage that is at the heart of research into aging ...

Apr 05, 2017
popularity27 comments 0

Are tumor cells glutamine addicts?

Most cancers require large amounts of glutamine for rapid growth and there are numerous studies indicating that they cannot survive without it, a phenomenon termed "glutamine addiction". This has fueled the idea that preventing ...

Apr 13, 2017
popularity2 comments 0